Literature DB >> 10623737

Glial cell-specific regulation of the JC virus early promoter by large T antigen.

H S Kim1, N M Goncalves, J W Henson.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease that results from an oligodendrocyte infection caused by JC virus. The JC virus early promoter directs cell-specific expression of the viral replication factor large T antigen, and thus transcriptional regulation constitutes a major mechanism of glial tropism in PML. We have previously demonstrated that T antigen controls the JC virus basal promoter in a glial cell-specific manner, since T antigen repressed the JC virus and simian virus 40 (SV40) early promoters in glioma cells but induced strong activation of the JC virus early promoter in nonglial cells. To further analyze these findings, T antigen and nuclear extracts from glial and nonglial cells were used to examine DNase I footprints on the proximal promoter. T-antigen binding to site II was more extensive than expected based on sequence homology with SV40, and nuclear proteins protected several regions of the proximal promoter in a cell-specific manner. Multiple Sp1 binding domains were identified. Site-directed mutagenesis revealed that T-antigen-mediated activation required a TATA box sequence, a pentanucleotide repeat immediately upstream of the TATA box, and an Sp1 binding site downstream of the TATA box. When footprints were obtained with mutant promoters which blocked T-antigen-induced transactivation, no change in T-antigen binding was observed. These results suggest that T antigen activates the JC virus basal promoter in nonglial cells by interaction with the transcription initiation complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623737      PMCID: PMC111595          DOI: 10.1128/jvi.74.2.755-763.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  A 53 kDa protein binds to the negative regulatory region of JC virus early promoter.

Authors:  A K Sharma; G Kumar
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

2.  Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus.

Authors:  K Amemiya; R Traub; L Durham; E O Major
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

3.  JC virus enhancer-promoter active in human brain cells.

Authors:  S Kenney; V Natarajan; D Strike; G Khoury; N P Salzman
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

4.  SV40 gene expression is modulated by the cooperative binding of T antigen to DNA.

Authors:  R M Myers; D C Rio; A K Robbins; R Tjian
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

5.  Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain.

Authors:  J T Kadonaga; K R Carner; F R Masiarz; R Tjian
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

6.  Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation.

Authors:  H Tada; M Lashgari; J Rappaport; K Khalili
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE.

Authors:  G ZURHEIN; S M CHOU
Journal:  Science       Date:  1965-06-11       Impact factor: 47.728

9.  Stimulation of the human heat shock protein 70 promoter in vitro by simian virus 40 large T antigen.

Authors:  I C Taylor; W Solomon; B M Weiner; E Paucha; M Bradley; R E Kingston
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

10.  SV40 T antigen binding site mutations that affect autoregulation.

Authors:  D C Rio; R Tjian
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

View more
  6 in total

1.  Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Authors:  Yoichi Kondo; Martha S Windrem; Lisa Zou; Devin Chandler-Militello; Steven J Schanz; Romane M Auvergne; Sarah J Betstadt; Amy R Harrington; Mahlon Johnson; Alexander Kazarov; Leonid Gorelik; Steven A Goldman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

Review 2.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors.

Authors:  So-Young Kim; Moon-Sook Woo; Won-Ki Kim; Eung-Chil Choi; John W Henson; Hee-Sun Kim
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.

Authors:  Gretchen V Gee; Bethany A O'Hara; Aaron Derdowski; Walter J Atwood
Journal:  Virus Res       Date:  2013-10-04       Impact factor: 3.303

Review 5.  New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Anna Teresa Palamara; Lucia Nencioni; Valeria Pietropaolo
Journal:  Clin Dev Immunol       Date:  2013-04-17

Review 6.  Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.

Authors:  Elizabeth A Mills; Yang Mao-Draayer
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.